ELEV
Elevation Oncology
ELEV
ELEV
Delisted
ELEV was delisted on the 22nd of July, 2025.
63 hedge funds and large institutions have $226M invested in Elevation Oncology in 2024 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 7 closing their positions.
Holders
63
Holders Change
+31
Holders Change %
+96.88%
% of All Funds
0.91%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
38
Increased
13
Reduced
9
Closed
7
Calls
$4K
Puts
–
Net Calls
+$4K
Net Calls Change
+$4K
Top Buyers
Top Sellers
1 |
1
Millennium Management
New York
|
$3.43M |
2 |
IC
2
Ikarian Capital
Dallas,
Texas
|
$760K |
3 |
TCM
3
Tang Capital Management
San Diego,
California
|
$15.7M |
4 |
O
4
OrbiMed
New York
|
$4.83M |
5 |
SFM
5
Sphera Funds Management
Tel Aviv,
Israel
|
$2.21M |